MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

Recruiting
Conditions
Neoplasms
Healthy Volunteers
Hematologic Neoplasms
First Posted Date
2003-10-10
Last Posted Date
2025-05-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
6000
Registration Number
NCT00071045
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Outcomes of Sleep Disorders in Older Men

Completed
Conditions
Heart Diseases
Sleep Apnea Syndromes
Cardiovascular Diseases
Sleep
Neurologic Manifestations
Bone Diseases
Osteoporosis
First Posted Date
2003-10-09
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00070681

Inflammatory Genomics in Human Carotid Artery Disease

Completed
Conditions
Cardiovascular Diseases
Atherosclerosis
Carotid Artery Diseases
Inflammation
First Posted Date
2003-10-09
Last Posted Date
2008-08-21
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00070668

Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease

Phase 2
Completed
Conditions
Coronary Arteriosclerosis
First Posted Date
2003-09-30
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
42
Registration Number
NCT00069654
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Cardiac Function in Patients With Hereditary Hemochromatosis

Completed
Conditions
Hereditary Hemochromatosis
First Posted Date
2003-09-09
Last Posted Date
2024-05-03
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
70
Registration Number
NCT00068159
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Phase 2
Terminated
Conditions
Chronic Myeloproliferative Disorders
Leukemia
Myelodysplastic/Myeloproliferative Diseases
First Posted Date
2003-08-07
Last Posted Date
2013-05-01
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
51
Registration Number
NCT00066417
Locations
🇺🇸

NIH - Warren Grant Magnuson Clinical Center, Bethesda, Maryland, United States

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase 2
Completed
Conditions
Leukemia
First Posted Date
2003-07-28
Last Posted Date
2015-04-28
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00006240
Locations
🇺🇸

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States

🇺🇸

Mount Sinai Medical Center, NY, New York, New York, United States

🇺🇸

National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States

and more 1 locations

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Phase 2
Completed
Conditions
Aplastic Anemia
Interventions
First Posted Date
2003-07-21
Last Posted Date
2021-07-21
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
54
Registration Number
NCT00065260
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Technical Development of Cardiovascular Magnetic Resonance Imaging

Phase 1
Completed
Conditions
Peripheral Artery Disease
First Posted Date
2003-07-15
Last Posted Date
2017-10-30
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
37
Registration Number
NCT00064896
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes

Phase 2
Completed
Conditions
Congestive Heart Failure
First Posted Date
2003-07-11
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
50
Registration Number
NCT00064727
Locations
🇺🇸

National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike, Bethesda, Maryland, United States

🇺🇸

Suburban Hospital, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath